Regenxbio RGNX
NASDAQ RGNX
$7.43 +0.01 (+0.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Invested Capital (2014)

Updated

Regenxbio's Invested Capital came in at -$15.89 million for Q4 2014.

Analysis

Regenxbio (RGNX) Invested Capital (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Regenxbio 401.90 Mn -531.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -15.89 Mn
API Access

Regenxbio Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=RGNX&period=max&api_key=YOUR_API_KEY